Cerba Healthcare News and Activities

Cerba Healthcare is owned by EQT.

EQT is one of the...

• Forbes Global 2000 (#1281);
• Russell 3000;
• Stoxx 600;
• TOB Iconic 10,000.

EQT is a company listed under the stock ticker EQT (SE).

EQT has a direct presence in 21 countries.

EQT has 67 subsidiaries including Alastin Skincare, Anticimex and Arcwood Environmental.

They are in:

• Food16%
• Business Services10%
• Other74%

Acquisition, funding and merger involving EQT.

• EQT has announced the acquisition of Intertek Group  (posted on June 19 2026).
• EQT has announced the acquisition of Coller Capital  (posted on January 23 2026).
• EQT has announced the acquisition of Adalvo  (posted on July 21 2025).
• EQT has acquired Seven Seas Water (posted on May 23 2025).
• EQT has acquired Perficient (posted on October 3 2024).
• WSO2 and EQT have announced they will merge  (posted on August 19 2024)..
• See more news about EQT Hide news involving EQT

View the org chart displaying its 23 main executives

Most searched biographies at Cerba Healthcare

• Aurélie Driss-Corbin, Chief Executive Officer
• Eric Ellul, Supervisory Board Member
• Samuel Dalens, Supervisory Board Member

Popular executive movements at EQT

• Gustav Segerberg who is Head of Chief Executive Officer Office, will be promoted to Chief Financial Officer on Jul. 18, 2026  (posted on June 11 2026).
• Kim Henriksson who is Chief Financial Officer, will become Senior Advisor on Jul. 18, 2026  (posted on June 11 2026).
• Jean Eric Salata, who was Head of EQT Private Capital Asia and Chairperson of EQT Asia, is promoted to Chairman of the Board  (posted on May 28 2026).

Click here to view some more movements at EQT

Create your alert
to follow the executive moves at Cerba Healthcare.

EQT has 2,411 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Alvotech has just announced a $165 Million fundraising (posted on June 19 2026).
• Obsidian Therapeutics has filed its IPO. Its stock ticker will be OBX. (posted on June 18 2026).
• PharmaEssentia has acquired Forus Therapeutics (posted on June 18 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Cerba Healthcare

• Earlier diagnosis of Alzheimer’s disease through an innovative test available from a simple blood sample | Cerbahealtcare

Social media about Cerba Healthcare

• Cerba Healthcare on Wikipedia, Google News & Yahoo Finance
• Cerba Healthcare on LinkedIn, X (Twitter) & YouTube